Kahts, MarykeMellet, JuanitaDurandt, ChrisnaMoodley, KinoshaSummers, BeverleyEbenhan, ThomasZeevaart, Jan RijnAras, OmerPepper, Michael Sean2025-02-132025-02-132024-11Kahts, M., Mellet, J., Durandt, C., Moodley, K., Summers, B., Ebenhan, T., Zeevaart, J.R., Aras, O. & Pepper, M.S. A proof-of-concept study to investigate the radiolabelling of human mesenchymal and hematopoietic stem cells with [89Zr]Zr-Df-Bz-NCS. EJNMMI Radiopharmacy and Chemistry 2024 Nov 29; 9(1): 82. doi: 10.1186/s41181-024-00311-w.2365-421X (online)10.1186/s41181-024-00311-whttp://hdl.handle.net/2263/100807DATA AVAILABITY STATEMENT: The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.Please read abstract in article.en© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.Mesenchymal stem cells (MSCs)Hematopoietic stem and progenitor cells (HSPCs)Cell labellingIn vivo cell trackingZirconium-89SDG-03: Good health and well-beingSDG-09: Industry, innovation and infrastructurePositron emission tomography (PET)A proof-of-concept study to investigate the radiolabelling of human mesenchymal and hematopoietic stem cells with [89Zr]Zr-Df-Bz-NCSArticle